Why the study?
Conduction disturbances are common after TAVR and depend on anatomical and device factors; this study evaluated whether membranous septum length predicts conduction disturbance risk across different devices.
Does membranous septum length predict the risk of major conduction disturbances in patients undergoing TAVR?
Does membranous septum length predict the risk of major conduction disturbances in patients undergoing TAVR?
A shorter membranous septum length and negative ΔMSID increase the risk of conduction disturbances after TAVR, suggesting preoperative CT assessment can guide device selection.
Answers are grounded in this paper and cite their sources.
MS length may stratify conduction risk after TAVR; leaves open whether preoperative CT should guide device selection.
BACKGROUND: Conduction disturbances (CD) are one of the most common adverse events after transcatheter aortic valve replacement (TAVR), and seem to be dependent on the device used as well as anatomical factors. AIMS: The aim of this study was to evaluate whether the length of the membranous septum (MS) could provide useful information about the risk of CD and to examine the impact of the MS on CD after TAVR using different devices. METHODS: This study included 140 patients undergoing TAVR with a balloon‑expandable valve or self‑‑expanding valve. The length of the MS was assessed by preoperative computed tomography. ΔMSID was calculated as the length of the MS minus implantation depth. RESULTS: A total of 24 patients (17%) received a permanent pacemaker (PPM), 53 (38%) developed new‑‑onset left bundle‑branch block (LBBB) following TAVR. The MS length was shown to be the strongest independent predictor of new‑onset LBBB (odds ratio [OR], 3.05; 95% CI, 1.96-4.77; P <0.001) and PPM implantation (OR, 3.76; 95% CI, 2.01-7.06; P <0.001). ΔMSID was also inversely associated with the development of LBBB and the need for PPM. In a head‑to‑head comparison, ΔMSID values were found to be statistically lower in the self‑expanding valve group (-0.8 mm vs 0.7 mm; P <0.001). CONCLUSIONS: A short MS and ΔMSID with a negative value increase the risk of CD. Assessment of the MS length prior to TAVR might serve as an additional tool to guide clinical decision‑making and appropriate device selection to reduce the the risk of CD.
No takes yet. Share an insight, caveat, or question.
Aslan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: